Narendra Wajapeyee PhD

Assistant Professor of Pathology

Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Medicine, Pharmacology, and Physiology

Signal Transduction

Pathology: Wajapeyee Lab

Research Interests

Cancer; Genomics; RNAi; Senescence; DNA methylation; RNAi delivery to cancer cells  more...


  • Ph.D., Indian Institute of Science, India, 2005

Selected Publications

  • Romi Gupta, Yuying Dong, Peter D. Solomon, Hiromi I Wettersten, Christopher Cheng, Jin-Na Min, Jeremy D. Henson, Shaillay K. Dogra, Sung H. Hwang, Bruce D. Hammock, Lihua J. Zhu, Roger R. Reddel, W. Mark Saltzman, Robert H. Weiss, Sandy Chang, Michael R. Green and Narendra Wajapeyee. Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A. Proc Natl Acad Sci USA, June 27, 2014 (in press).
  • Ling Lin, Lynn Chamberlain, Magnolia L. Pak, Arvindhan Nagarajan, Romi Gupta, Lihua J. Zhu, Casey M. Wright, Kwun M. Fong, Narendra Wajapeyee and Michael R. Green. A Large-Scale RNAi-Based Mouse Tumorigenesis Screen Identifies New Lung Cancer Tumor Suppressors that Repress FGFR Signaling. June 27, 2014. Cancer Discovery (in press).
  • Arvindhan Nagarajan, Shaillay K. Dogra, Alex Y. Liu, Michael R. Green and Narendra Wajapeyee. PEA15 regulates the DNA damage induced cell cycle checkpoint and oncogene-directed transformation. Molecular and Cellular Biology, 2014 Jun 15;34(12):2264-2282. Epub 2014 Apr 7.



Latest News


Edit Profile